Vorasidenib approved in UK for treating IDH-mutant brain tumours
16th September 2025 Uncategorised 0
MHRA greenlights oral therapy for patients aged 12 and over with grade 2 astrocytoma

More: Vorasidenib approved in UK for treating IDH-mutant brain tumours
Source: News
